Skip to main content

New and competing renewal awards, July 2016

Friday, August 5, 2016
Duke Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of July 2016.  

Priya Kishnani (Medical Genetics) has received an award from Shire Human Genetic Therapies in the amount of $125,000 for a project entitled, “Medical Education and Awareness Program for Future Health Care Providers Treating Patients with Rare Genetic and Metabolic Diseases.” The project period is 8/1/2016 – 7/31/2017.

Yong-Hui Jiang (Medical Genetics) has received an award from Sage Therapeutics in the amount of $249,781 for a project entitled, “Sage Therapeutics Collaboration.” The project period is 7/1/2016 – 6/30/2017.

Priya Kishnani (Medical Genetics) has received an award from the University of Minnesota in the amount of $81,640 for a project entitled, “CRIM Responses in Pompe Disease.” The project period is 8/1/2015 – 7/31/2019.

Michael Armstrong (Hematology-Oncology) has received an award from the V Foundation for Cancer Research in the amount of $80,000 for a project entitled, “Genetically Engineered Mouse Models of Neuroblasotma: The Impact of Mxi1 and Mxi0 Loss.” The project period is 8/15/2016 – 8/15/2017.

Debra Best (Primary Care) has received an award from the American Academy of Pediatrics in the amount of $75,000 for a project entitled, “Carolinas Collaborative: Community-Pediatric Partnerships for Promotion of Child Health and Prevention of Toxic Stress.” The project period is 7/1/2016 – 9/30/2018.

Ronald Goldberg (Neonatology) has received an award from the Zeist Foundation Inc. in the amount of $100,000 for a project entitled, “Jean and George Brumley Jr. Clinical Scholars Program.” The project period is 7/1/2016 – 6/30/2017.

Alexander Hartemink (Computer Science) and Gregory Crawford (Medical Genetics) have received an award from NIH in the amount of $392,484 for a project entitled, “Exploring the Role of Dynamic Chromatin Occupancy in Transcriptional Regulation.” The project period is 4/1/2016 – 3/31/2020. 

Edward Smith (Neurology) has received an award from GlaxoSmithKline in the amount of $172,367 for a project entitled, “A Study to Evaluate Potential Biomarkers of Muscular Dystrophy.” The project period is 8/8/2016 – 1/1/2018.

Patricia Ashley (Neonatology) has received an award from Infant Bacterial Therapeutics AB in the amount of $165,000 for a project entitled, “A Randomized, Double Blind, Parallel-Group, Dose Escalation Placebo-Controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.” The project period is 7/1/2016 – 4/30/2018.

Richard Kravitz (Pulmonary and Sleep Medicine) has received an award from Anthera Pharmaceuticals in the amount of $114,940 for a project entitled, “A Phase 3, Open Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency.” The project period is 7/1/2016 – 7/31/2018.

Priya Kishnani (Medical Genetics) has received an award from Alexion Pharmaceuticals in the amount of $276,978 for a project entitled, “A Phase 2A, Randomized, Multicenter, Open-Label, Pharmacokinetic, and Dose Response Study of Asfotase Alfa in Adult Patients with Pediatric-Onset Hypophosphatasia.” The project period is 5/1/2016 – 5/31/2018.

Daniel Wechsler (Hematology-Oncology) has received an award from St. Baldrick’s Foundation in the amount of $100,000 for a project entitled, “Mechanisms of CRM1-Dependent HOXA Gene Activation in Pediatric Leukemias.” The project period is 7/1/2016 – 6/30/2017.

Michael Armstrong (Hematology-Oncology) has received an award from United Therapeutics in the amount of $105,592 for a project entitled, “A Post-Marketing Study to Further Assess the Immunogenicity and Safety of Unituxin in High-Risk Neuroblastoma Patients.” The project period is 5/31/2016 – 6/30/2019.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Professor of Pediatrics
Vice Chair for Research
Chief, Global Health